Bayer Stock

Bayer Stocks 2024

Bayer Stocks

982.42 M

Ticker

BAYN.DE

ISIN

DE000BAY0017

WKN

BAY001

In 2024, Bayer had 982.42 M outstanding stocks, a 0% change from the 982.42 M stocks in the previous year.

The Bayer Stocks history

YEARNUMBER OF STOCKS (undefined EUR)
2029e982.42
2028e982.42
2027e982.42
2026e982.42
2025e982.42
2024e982.42
2023982.42
2022982.42
2021982.42
2020982.42
2019981.69
2018940.76
2017885.19
2016845.95
2015840.31
2014840.31
2013840
2012840
2011840
2010840
2009839
2008838
2007837
2006805
2005742
2004742

Bayer shares outstanding

The number of shares was Bayer in 2023 — This indicates how many shares 982.42 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Bayer earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Bayer's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Bayer’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Bayer's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Bayer Aktienanalyse

What does Bayer do?

Bayer AG is a German company that was founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott in Wuppertal. The company started out as a manufacturer of dyes, but over time it has evolved into a leading global agrochemical, health, and life science company. Bayer's business model is based on the goal of finding innovative solutions to the societal challenges of the future. This includes promoting agriculture and health, as well as sustainability and the preservation of natural resources. Bayer specializes in three business areas: Pharmaceuticals, Consumer Health, and Crop Science. In the Pharmaceuticals division, Bayer develops and markets innovative drugs for a variety of diseases. The company focuses on research and development in key therapy areas such as cardiology, oncology, hematology, neurology, and immunology. Well-known and successful brands from Bayer in the Pharmaceuticals sector include Xarelto, Kogenate, Stivarga, Eylea, and Nexavar. In the Consumer Health division, Bayer develops and distributes products for consumer health and well-being. This includes self-medication products, dietary supplements, contact lens care products, and animal health products. Well-known brands from Bayer Consumer Health include Aspirin, Bepanthen, Berocca, Coppertone, and Advantage. In the Crop Science division, Bayer develops and markets products and solutions for agriculture. This includes crop protection products, seeds, plant breeding, and digital farming. The goal is to help farmers worldwide operate sustainably and productively to meet the growing demand for food. Well-known brands from Bayer Crop Science include Roundup, Decis, Diflubenzuron, and Dekalb. Bayer is known for its innovative power and has made many inventions and discoveries throughout its history. It was one of the first companies to develop synthetic dyes, and in 1897, it was also the first company in Germany to manufacture Aspirin. Since then, Bayer has made numerous groundbreaking discoveries and is now at the forefront of the pharmaceutical and agrochemical industry. Bayer is headquartered in Leverkusen and operates in over 90 countries worldwide. The company employs over 100,000 people and had a turnover of around 41 billion euros in 2020. The company is also committed to reducing its ecological footprint in line with its business goals and strives to improve sustainability in its value chain. Bayer ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Bayer revenue by segment

  • 41 % Pharmaceuticals

  • 13 % Consumer Health

  • 1 % All Other Segments

  • 45 % Crop Science

Stocks Details

Evaluating Bayer's Shares Outstanding

Bayer's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Bayer’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Bayer’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Bayer’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Bayer stock

How many stocks are there of Bayer?

The current number of stocks of Bayer is 982.42 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Bayer are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Bayer evolved in recent years?

The number of shares of Bayer has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Bayer as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Bayer?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Bayer pay?

Over the past 12 months, Bayer paid a dividend of 2.4 EUR . This corresponds to a dividend yield of about 12.31 %. For the coming 12 months, Bayer is expected to pay a dividend of 2.43 EUR.

What is the dividend yield of Bayer?

The current dividend yield of Bayer is 12.31 %.

When does Bayer pay dividends?

Bayer pays a quarterly dividend. This is distributed in the months of May, June, June, May.

How secure is the dividend of Bayer?

Bayer paid dividends every year for the past 26 years.

What is the dividend of Bayer?

For the upcoming 12 months, dividends amounting to 2.43 EUR are expected. This corresponds to a dividend yield of 12.45 %.

In which sector is Bayer located?

Bayer is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bayer kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bayer from 5/2/2024 amounting to 0.11 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.

When did Bayer pay the last dividend?

The last dividend was paid out on 5/2/2024.

What was the dividend of Bayer in the year 2023?

In the year 2023, Bayer distributed 2 EUR as dividends.

In which currency does Bayer pay out the dividend?

The dividends of Bayer are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bayer stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Bayer

Our stock analysis for Bayer Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bayer Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.